EAACI Congress 2025

Back
13 - 16 June 2025 Glasgow, United Kingdom

Amlitelimab Reduces Th2-, Th1-, and Th17/22-Related Gene Expression and Protein Levels in Adults With Moderate-to-Severe Atopic Dermatitis: Results From an Exploratory Analysis of the Phase 2b STREAM-AD Study

Saturday 14 Jun, 15:24 PM - 15:36 PM Glasgow, United Kingdom